As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

Fintel reports that on July 17, 2025, Goldman Sachs initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) ...

S&P 500 E-Mini futures (ESU25) are up +0.07%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are up +0.16% this morning, pointing to a muted open on Wall Street after yesterday’s volatile session, ...

Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...

Mukul Mehta, currently Head of Business Planning and Analysis (BPA), Digital Finance and Tax, has been appointed Chief Financial Officer, effective March 16, 2026, and will join the Executive ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Integrated, tech-forward platforms are going to define the next chapter of healthcare commercialization, and this merger puts ...

Increasing patient demand, barriers to access, and elevated costs are pushing healthcare providers to reconsider traditional ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

A new survey has found that the use of AI and real-world data (RWD) is on the rise across the biopharma industry, but hurdles ...